company background image
SGBI logo

Sangui Biotech International OTCPK:SGBI Stock Report

Last Price

US$0.0015

Market Cap

US$454.5k

7D

0%

1Y

n/a

Updated

27 Mar, 2024

Data

Company Financials

Sangui Biotech International, Inc.

OTCPK:SGBI Stock Report

Market Cap: US$454.5k

SGBI Stock Overview

Sangui Biotech International, Inc., through its subsidiaries, engages in the manufacturing and sales of wound treatment and cosmetic products.

SGBI fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Sangui Biotech International, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sangui Biotech International
Historical stock prices
Current Share Price€0.0015
52 Week High€0.02
52 Week Low€0.0012
Beta-0.28
1 Month Change0%
3 Month Change-48.28%
1 Year Changen/a
3 Year Change-96.88%
5 Year Change-94.13%
Change since IPO-99.95%

Recent News & Updates

Recent updates

Shareholder Returns

SGBIUS BiotechsUS Market
7D0%0.9%0.4%
1Yn/a10.3%28.8%

Return vs Industry: Insufficient data to determine how SGBI performed against the US Biotechs industry.

Return vs Market: Insufficient data to determine how SGBI performed against the US Market.

Price Volatility

Is SGBI's price volatile compared to industry and market?
SGBI volatility
SGBI Average Weekly Movementn/a
Biotechs Industry Average Movement11.6%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: SGBI's share price has been volatile over the past 3 months.

Volatility Over Time: Insufficient data to determine SGBI's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1995n/aThomas Striepehttps://www.sanguibiotech.com

Sangui Biotech International, Inc., through its subsidiaries, engages in the manufacturing and sales of wound treatment and cosmetic products. The company offers artificial oxygen carriers comprising oxygen carrying blood additives and oxygen carrying blood volume substitutes; nano formulations for the regeneration of skin; chitoskin wound pads; Hemospray, a hemoglobin based wound spray; and wound dressing spray under the Granulox brand. Sangui Biotech International, Inc. was incorporated in 1995 and is headquartered in Hamburg, Germany.

Sangui Biotech International, Inc. Fundamentals Summary

How do Sangui Biotech International's earnings and revenue compare to its market cap?
SGBI fundamental statistics
Market capUS$454.48k
Earnings (TTM)-US$100.32k
Revenue (TTM)US$96.26k

4.7x

P/S Ratio

-4.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SGBI income statement (TTM)
RevenueUS$96.26k
Cost of RevenueUS$0
Gross ProfitUS$96.26k
Other ExpensesUS$196.58k
Earnings-US$100.32k

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.00048
Gross Margin100.00%
Net Profit Margin-104.22%
Debt/Equity Ratio-72.8%

How did SGBI perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.